Free Trial

CME Group (CME) Stock Price, News & Analysis

CME Group logo
$238.01 -0.52 (-0.22%)
(As of 05:45 PM ET)

About CME Group Stock (NASDAQ:CME)

Key Stats

Today's Range
$235.81
$238.58
50-Day Range
$221.17
$246.02
52-Week Range
$190.70
$249.02
Volume
1.62 million shs
Average Volume
1.97 million shs
Market Capitalization
$85.77 billion
P/E Ratio
25.03
Dividend Yield
1.93%
Price Target
$229.33
Consensus Rating
Hold

Company Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

CME Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
88th Percentile Overall Score

CME MarketRank™: 

CME Group scored higher than 88% of companies evaluated by MarketBeat, and ranked 132nd out of 935 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CME Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 4 buy ratings, 7 hold ratings, and 4 sell ratings.

  • Amount of Analyst Coverage

    CME Group has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CME Group's stock forecast and price target.
  • Earnings Growth

    Earnings for CME Group are expected to grow by 1.37% in the coming year, from $10.22 to $10.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CME Group is 25.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.34.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CME Group is 25.03, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 24.97.

  • Price to Earnings Growth Ratio

    CME Group has a PEG Ratio of 5.41. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    CME Group has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.36% of the outstanding shares of CME Group have been sold short.
  • Short Interest Ratio / Days to Cover

    CME Group has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CME Group has recently increased by 28.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CME Group pays a meaningful dividend of 1.93%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CME Group has been increasing its dividend for 14 years.

  • Dividend Coverage

    The dividend payout ratio of CME Group is 48.37%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CME Group will have a dividend payout ratio of 44.40% next year. This indicates that CME Group will be able to sustain or increase its dividend.

  • Read more about CME Group's dividend.
  • Percentage of Shares Shorted

    1.36% of the outstanding shares of CME Group have been sold short.
  • Short Interest Ratio / Days to Cover

    CME Group has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CME Group has recently increased by 28.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    CME Group has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for CME Group this week, compared to 15 articles on an average week.
  • Search Interest

    17 people have searched for CME on MarketBeat in the last 30 days. This is an increase of 21% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 160% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CME Group insiders have sold 62,755.49% more of their company's stock than they have bought. Specifically, they have bought $2,622.00 in company stock and sold $1,648,071.00 in company stock.

  • Percentage Held by Insiders

    Only 0.30% of the stock of CME Group is held by insiders.

  • Percentage Held by Institutions

    87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CME Group's insider trading history.
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

CME Stock News Headlines

stock buybacks money exchange
4 Stocks Planning to Return Capital With Hefty Buyback Programs (CME)
Check out these four stocks that recently announced substantial share buyback programs to return capital back to their shareholders.
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
See More Headlines

CME Stock Analysis - Frequently Asked Questions

CME Group's stock was trading at $210.60 at the start of the year. Since then, CME stock has increased by 13.0% and is now trading at $238.01.
View the best growth stocks for 2024 here
.

CME Group Inc. (NASDAQ:CME) issued its quarterly earnings results on Wednesday, October, 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. The company's quarterly revenue was up 18.4% compared to the same quarter last year.
Read the conference call transcript
.

CME Group's board approved a share repurchase plan on Thursday, December 5th 2024, which authorizes the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's board of directors believes its stock is undervalued.

Top institutional investors of CME Group include State Street Corp (4.41%), Geode Capital Management LLC (2.30%), Vontobel Holding Ltd. (0.95%) and Fiera Capital Corp (0.92%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Julie Holzrichter, Hilda Harris Piell, Sunil Cutinho, Julie Winkler, Martin J Gepsman, Elizabeth A Cook, Terry L Savage, Terry L Savage, Daniel R Glickman, Lynne Fitzpatrick, Ken Vroman, Timothy S Bitsberger, Derek Sammann, Timothy Francis Mccourt, Charles P Carey, Dennis Suskind, William R Shepard, Sean Tully and Kevin Kometer.
View institutional ownership trends
.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
10/23/2024
Ex-Dividend for 12/27 Dividend
12/09/2024
Today
12/23/2024
Ex-Dividend for 1/16 Dividend
12/27/2024
Dividend Payable
12/27/2024
Fiscal Year End
12/31/2024
Dividend Payable
1/16/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Current Symbol
NASDAQ:CME
CUSIP
12572Q10
Employees
3,565
Year Founded
1848

Price Target and Rating

Average Stock Price Target
$229.33
High Stock Price Target
$260.00
Low Stock Price Target
$180.00
Potential Upside/Downside
-3.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
15 Analysts

Profitability

Net Income
$3.23 billion
Pretax Margin
73.64%

Debt

Sales & Book Value

Annual Sales
$6.04 billion
Cash Flow
$10.62 per share
Book Value
$74.43 per share

Miscellaneous

Free Float
359,281,000
Market Cap
$85.77 billion
Optionable
Optionable
Beta
0.56

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:CME) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners